Turning an SPA rejection into BLA Submission Success
Veristat supported a Sponsor from SPA rejection to BLA submission, bringing strategic expertise to a small client team tackling their first clinical...
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.
1 min read
JoAnn Vormschlag : Published Updated
On Saturday, February 27, 2016, Team Veristat will ride in the Boston Cycle for Survival Event taking place at The Equinox in Boston, MA.
This will be Team Veristat's 2nd year participating in the event, where we will have 16 Veristat riders on 4 bikes with a team goal of raising $20,000 for the fight against rare cancers.
Every day, our teams work hard to support the many pharmaceutical and biotechnology firms who are developing and testing new treatments, but there is still more research to do which is why we support Cycle for Survival.
Please JOIN THE BATTLE by making a donation today!
Cycle for Survival is the national movement to beat rare cancers. About half of all cancer patients are fighting a rare cancer -- Leukemia, lymphoma, pancreatic cancer, bladder cancer, ovarian cancer, and all pediatric cancers are just some of the many rare forms of the disease. These patients often face limited or no treatment options. Since 2007, Cycle for Survival has raised over $50 million through its signature high-energy, indoor, team cycling events; funding pioneering rare cancer research led by Memorial Sloan Kettering Cancer Center. Together with the movement's founding partner, Equinox, Cycle for Survival has supported over 100 innovative clinical trials, research studies, and major research initiatives.
Donate TodayPlease consider making a donation to team Veristat and helping us raise money to fund research for curing rare cancers.
Veristat supported a Sponsor from SPA rejection to BLA submission, bringing strategic expertise to a small client team tackling their first clinical...
Discover how Veristat's expertise in IND submissions and strategic planning paved the way for a small-sized biotech company to advance into a Phase I...
Veristat supports the battle against rare cancers by participating in the Cycle for Survival